[go: up one dir, main page]

ATE466020T1 - Neue isoform des gefässendothelzell wachstumshemmers (vegi) - Google Patents

Neue isoform des gefässendothelzell wachstumshemmers (vegi)

Info

Publication number
ATE466020T1
ATE466020T1 AT02793986T AT02793986T ATE466020T1 AT E466020 T1 ATE466020 T1 AT E466020T1 AT 02793986 T AT02793986 T AT 02793986T AT 02793986 T AT02793986 T AT 02793986T AT E466020 T1 ATE466020 T1 AT E466020T1
Authority
AT
Austria
Prior art keywords
vegi
isoforms
vascular
cell growth
growth inhibitor
Prior art date
Application number
AT02793986T
Other languages
English (en)
Inventor
Luyuan Li
Hongguang Pan
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Application granted granted Critical
Publication of ATE466020T1 publication Critical patent/ATE466020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02793986T 2001-11-09 2002-11-12 Neue isoform des gefässendothelzell wachstumshemmers (vegi) ATE466020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33119001P 2001-11-09 2001-11-09
PCT/US2002/037426 WO2003039491A2 (en) 2001-11-09 2002-11-12 Novel isoforms of vascular endothelial cell growth inhibitor

Publications (1)

Publication Number Publication Date
ATE466020T1 true ATE466020T1 (de) 2010-05-15

Family

ID=23292954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793986T ATE466020T1 (de) 2001-11-09 2002-11-12 Neue isoform des gefässendothelzell wachstumshemmers (vegi)

Country Status (10)

Country Link
US (2) US7498407B2 (de)
EP (1) EP1487854B1 (de)
CN (1) CN100398551C (de)
AT (1) ATE466020T1 (de)
AU (1) AU2002359446B2 (de)
CA (1) CA2465953A1 (de)
DE (1) DE60236212D1 (de)
ES (1) ES2345329T3 (de)
RU (1) RU2316591C2 (de)
WO (1) WO2003039491A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1255769E (pt) * 2000-01-25 2007-07-23 Oklahoma Med Res Found Procedimento universal para o re-enrolamento de proteínas recombinantes.
ES2345329T3 (es) 2001-11-09 2010-09-21 Georgetown University Nueva isoforma del inhibidor del crecimiento celular endotelial vascular (vegi).
CN1311076C (zh) * 2003-04-16 2007-04-18 普罗特奥姆技术公司 生产重组尿激酶的方法
WO2005058243A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
WO2005058930A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for production of recombinant vascular endothelial cell growth inhibitor
ES2611307T3 (es) 2005-08-30 2017-05-08 University Of Miami Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25)
US20070218535A1 (en) * 2005-11-28 2007-09-20 Xinli Lin Methods for production of recombinant alpha1-antitrypsin
CN101903402B (zh) 2007-11-13 2014-07-16 泰华生物制药美国公司 抗tl1a的人源化抗体
CN101503697B (zh) * 2009-03-09 2013-08-07 中山大学 一种人血管内皮细胞生长抑制因子rhVEGI-192A的重组蛋白的制备方法
CN101503474B (zh) * 2009-03-09 2012-07-04 中山大学 一种人血管内皮细胞生长抑制因子嵌合多肽及其制备方法和在靶向性抗肿瘤活性中的应用
KR20120089259A (ko) 2009-08-03 2012-08-09 유니버시티 오브 마이애미 Ｔ 조절 세포의 생체 내 확장 방법
CN102453097A (zh) * 2010-10-27 2012-05-16 上海科新生物技术股份有限公司 抑制血管新生的融合蛋白vf及药物组合物和应用
KR20150136047A (ko) 2013-01-09 2015-12-04 유니버시티 오브 마이애미 TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
US9918669B2 (en) 2014-08-08 2018-03-20 Medtronic Xomed, Inc. Wireless nerve integrity monitoring systems and devices
CN112587504B (zh) * 2016-10-17 2022-10-18 南京绿叶制药有限公司 一种抑制bcl-2的反义寡聚核酸的脂质纳米粒及其制备方法
CN111569051B (zh) * 2020-05-11 2021-10-22 中山大学 人血管内皮细胞抑制因子vegi-251在制备抗肿瘤药物中的应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
JP2752788B2 (ja) 1989-01-23 1998-05-18 カイロン コーポレイション 感染および過剰増殖障害の為の組換え療法
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP0737750B1 (de) 1989-03-21 2003-05-14 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991002805A2 (en) 1989-08-18 1991-03-07 Viagene, Inc. Recombinant retroviruses delivering vector constructs to target cells
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
ZA911974B (en) 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
EP0648271B1 (de) 1991-08-20 2003-04-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
US5356926A (en) * 1992-02-24 1994-10-18 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
WO1993025234A1 (en) 1992-06-08 1993-12-23 The Regents Of The University Of California Methods and compositions for targeting specific tissue
CA2137361A1 (en) 1992-06-10 1993-12-23 W. French Anderson Vector particles resistant to inactivation by human serum
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP0911413A3 (de) 1992-12-03 2000-11-15 Genzyme Corporation Mindestadenovirus-Vector zur Gentherapie
DE69431750T2 (de) 1993-04-22 2003-04-03 Skyepharma Inc., San Diego Multivesikuläre liposomen mit verkapseltem cyclodextrin und pharmakologisch wirksamen verbindungen sowie verfahren zu deren verwendung
JP3532566B2 (ja) 1993-06-24 2004-05-31 エル． グラハム，フランク 遺伝子治療のためのアデノウイルスベクター
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
DK0814154T3 (da) 1993-09-15 2009-08-31 Novartis Vaccines & Diagnostic Rekombinante alfavirusvektorer
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
ATE437232T1 (de) 1993-10-25 2009-08-15 Canji Inc Rekombinanter adenoviren-vektor und verfahren zur verwendung
DE69433180T2 (de) 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara Felder von nukleinsaeuresonden auf biologischen chips
DE69425901T2 (de) 1993-11-16 2001-04-26 Skyepharma Inc., San Diego Vesikel mit gesteuerter wirkstofffreisetzung
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
CA2158977A1 (en) 1994-05-09 1995-11-10 James G. Respess Retroviral vectors having a reduced recombination rate
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
EP0792278B1 (de) 1994-11-07 2007-06-13 Human Genome Sciences, Inc. Tumornekrose-faktor-gamma
US6599719B2 (en) 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
JP2000504575A (ja) 1996-02-08 2000-04-18 アフィメトリックス，インコーポレイテッド 微生物のチップベースの種分化および表現型特徴付け
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
AU2998597A (en) 1996-05-06 1997-11-26 Chiron Corporation Crossless retroviral vectors
EP0892047A3 (de) 1997-07-09 2000-03-08 Hoechst Marion Roussel Deutschland GmbH Humanes und murines Semaphorin L
CN1174993C (zh) * 1997-11-03 2004-11-10 人体基因组科学有限公司 Vegi,一种血管发生和肿瘤生长的抑制剂
US20020111325A1 (en) 1997-11-03 2002-08-15 Human Genome Sciences, Inc. VEGI, an inhibitor of angiogenesis and tumor growth
US6146848A (en) 1998-07-23 2000-11-14 The Hong Kong University Of Science & Technology Bacterial expression system
AU4934099A (en) 1998-08-04 2000-02-28 Center For Advanced Science And Technology Incubation, Ltd. Method for enzymatic amplification of nucleic acid
AU5124500A (en) * 1999-04-30 2000-11-17 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
PT1255769E (pt) 2000-01-25 2007-07-23 Oklahoma Med Res Found Procedimento universal para o re-enrolamento de proteínas recombinantes.
PE20020908A1 (es) 2001-03-21 2002-10-26 Cell Therapeutics Inc Produccion recombinante de polimeros polianionicos y uso de de los mismos
ES2345329T3 (es) 2001-11-09 2010-09-21 Georgetown University Nueva isoforma del inhibidor del crecimiento celular endotelial vascular (vegi).
WO2005058243A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a

Also Published As

Publication number Publication date
US20090227014A1 (en) 2009-09-10
EP1487854B1 (de) 2010-04-28
US20030170242A1 (en) 2003-09-11
CN100398551C (zh) 2008-07-02
AU2002359446B2 (en) 2008-12-04
RU2316591C2 (ru) 2008-02-10
CN1668630A (zh) 2005-09-14
DE60236212D1 (de) 2010-06-10
US7498407B2 (en) 2009-03-03
RU2004117536A (ru) 2005-04-20
WO2003039491A3 (en) 2004-09-30
EP1487854A4 (de) 2006-01-04
WO2003039491A8 (en) 2003-10-30
ES2345329T3 (es) 2010-09-21
EP1487854A2 (de) 2004-12-22
US7750133B2 (en) 2010-07-06
CA2465953A1 (en) 2003-05-15
WO2003039491A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE466020T1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
ATE526041T1 (de) Verfahren zur hemmung okularer vorgänge
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
NO962304L (no) BMP-12, BMP-13 og sene-induserende sammensetninger derav
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
ATE481497T1 (de) Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
NO20021281D0 (no) Vaskul¶r beleggingssammensetning
DK1149111T3 (da) Fremgangsmåde og sammensætning til inhibering af angiogenese
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ATE275417T1 (de) Verwendung von vegf-c und vegf-d genen oder proteinen zur vorbeugung der restenose
SE8902532L (sv) Bestaemning av plasmaproteiner
ATE347611T1 (de) Automatischer apparat zum messen von wassertoxizität
ATE376428T1 (de) Metallkomplexverbindungen
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
NO20026286D0 (no) Nye peptider
DE60312684D1 (de) Plazenta-wachstumsfaktor als target für die behandlung von osteoporose
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
FR2803525B1 (fr) Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
DK1095275T3 (da) Endogen, konstitutivt aktiverede G-protein-koblede orphan-receptorer
DE60135489D1 (de) Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
SE0202608D0 (sv) New sequences

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties